528 related articles for article (PubMed ID: 25637346)
21. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.
Dursunoğlu D; Evrengül H; Polat B; Tanriverdi H; Cobankara V; Kaftan A; Kiliç M
Rheumatol Int; 2005 May; 25(4):241-5. PubMed ID: 15290086
[TBL] [Abstract][Full Text] [Related]
22. Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation.
Weber B; He Z; Yang N; Playford MP; Weisenfeld D; Iannaccone C; Coblyn J; Weinblatt M; Shadick N; Di Carli M; Mehta NN; Plutzky J; Liao KP
Arthritis Rheumatol; 2021 Jun; 73(6):970-979. PubMed ID: 33615723
[TBL] [Abstract][Full Text] [Related]
23. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
[TBL] [Abstract][Full Text] [Related]
24. Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study.
Raadsen R; Dijkshoorn B; van Boheemen L; Ten Boekel E; van Kuijk AWR; Nurmohamed MT
Joint Bone Spine; 2024 May; 91(3):105683. PubMed ID: 38161051
[TBL] [Abstract][Full Text] [Related]
25. Does a lack of physical activity explain the rheumatoid arthritis lipid profile?
AbouAssi H; Connelly MA; Bateman LA; Tune KN; Huebner JL; Kraus VB; Winegar DA; Otvos JD; Kraus WE; Huffman KM
Lipids Health Dis; 2017 Feb; 16(1):39. PubMed ID: 28187765
[TBL] [Abstract][Full Text] [Related]
26. Atherogenic lipid profile and high sensitive C-reactive protein in patients with rheumatoid arthritis.
Singh HV; Shrivastava AK; Raizada A; Singh SK; Pandey A; Singh N; Yadav D; Sharma H
Clin Biochem; 2013 Aug; 46(12):1007-1012. PubMed ID: 23578742
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory status modulates plasma lipid and inflammatory marker responses to kiwifruit consumption in hypercholesterolaemic men.
Gammon CS; Kruger R; Conlon CA; von Hurst PR; Jones B; Stonehouse W
Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):91-9. PubMed ID: 24099724
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
Popa C; van Tits LJ; Barrera P; Lemmers HL; van den Hoogen FH; van Riel PL; Radstake TR; Netea MG; Roest M; Stalenhoef AF
Ann Rheum Dis; 2009 Jun; 68(6):868-72. PubMed ID: 18635596
[TBL] [Abstract][Full Text] [Related]
30. Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study.
Filippatos TD; Derdemezis CS; Voulgari PV; Tsimihodimos V; Elisaf MS; Tselepis AD; Drosos AA
Scand J Rheumatol; 2013; 42(3):169-75. PubMed ID: 23311768
[TBL] [Abstract][Full Text] [Related]
31. Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis.
Lorber M; Aviram M; Linn S; Scharf Y; Brook JG
Br J Rheumatol; 1985 Aug; 24(3):250-5. PubMed ID: 3860273
[TBL] [Abstract][Full Text] [Related]
32. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
[TBL] [Abstract][Full Text] [Related]
33. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease.
Knowlton N; Wages JA; Centola MB; Alaupovic P
Scand J Rheumatol; 2012 May; 41(3):165-9. PubMed ID: 22401593
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.
Robertson J; Porter D; Sattar N; Packard CJ; Caslake M; McInnes I; McCarey D
Ann Rheum Dis; 2017 Nov; 76(11):1949-1952. PubMed ID: 28916714
[TBL] [Abstract][Full Text] [Related]
36. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
[TBL] [Abstract][Full Text] [Related]
37. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
[TBL] [Abstract][Full Text] [Related]
38. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
Kiortsis DN; Mavridis AK; Filippatos TD; Vasakos S; Nikas SN; Drosos AA
J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480
[TBL] [Abstract][Full Text] [Related]
39. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
Popa C; Netea MG; Radstake T; Van der Meer JW; Stalenhoef AF; van Riel PL; Barerra P
Ann Rheum Dis; 2005 Feb; 64(2):303-5. PubMed ID: 15231512
[TBL] [Abstract][Full Text] [Related]
40. Lipid profiles in untreated patients with rheumatoid arthritis.
Park YB; Lee SK; Lee WK; Suh CH; Lee CW; Lee CH; Song CH; Lee J
J Rheumatol; 1999 Aug; 26(8):1701-4. PubMed ID: 10451065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
